Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20030069492 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 10/299,524
Fecha de publicación10 Abr 2003
Fecha de presentación19 Nov 2002
Fecha de prioridad18 Dic 1990
También publicado comoUS5637089, US6165292, US6280539, US6379369, US6461453, US6592570, US6638372, US20020046785
Número de publicación10299524, 299524, US 2003/0069492 A1, US 2003/069492 A1, US 20030069492 A1, US 20030069492A1, US 2003069492 A1, US 2003069492A1, US-A1-20030069492, US-A1-2003069492, US2003/0069492A1, US2003/069492A1, US20030069492 A1, US20030069492A1, US2003069492 A1, US2003069492A1
InventoresRobert Abrams, Sepehr Fariabi
Cesionario originalAbrams Robert M., Sepehr Fariabi
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Superelastic guiding member
US 20030069492 A1
Resumen
An improved guiding member for use within a body lumen having a unique combination of superelastic characteristics. The superelastic alloy material has a composition consisting of about 30% to about 52% (atomic) titanium, and about 38% to 52% nickel and may have one or more elements selected from the group consisting of iron, cobalt, platinum, palladium, vanadium, copper, zirconium, hafnium and niobium. The alloy material is subjected to thermomechanical processing which includes a final cold working of about 10 to about 75% and then a heat treatment at a temperature between about 450° and about 600° C. and preferably about 475° to about 550° C. Before the heat treatment the cold worked alloy material is preferably subjected to mechanical straightening. The alloy material is preferably subjected to stresses equal to about 5 to about 50% of the room temperature ultimate yield stress of the material during the thermal treatment. The guiding member using such improved material exhibits a stress-induced austenite-to-martensite phase transformation at an exceptionally high constant yield strength of over 90 ksi for solid members and over 70 ksi for tubular members with a broad recoverable strain of at least about 4% during the phase transformation. An essentially whip free product is obtained.
Imágenes(4)
Previous page
Next page
Reclamaciones(32)
What is claimed is:
1. An intravascular guidewire comprising
a) an elongated member having a proximal portion and a distal portion and being formed at least in part of a superelastic alloy consisting essentially of about 30 to about 52% titanium, about 38 to about 52% nickel and up to 20% additional alloying elements selected from the group consisting of iron, cobalt, platinum, palladium, copper and vanadium, said alloy part having an austenite phase which has a final transformation temperature below about 45° C., which transforms to a martensite phase upon the application of stress and which has been thermomechanically formed in a procedure which includes a final cold working followed by a heat treatment at a temperature between about 450° to about 600° C. while applying tension to the cold worked elongated member; and
b) torquing means on the proximal end of the elongated member.
2. The guidewire of claim 1 wherein the alloy contains one or more additional alloying elements selected from the group consisting of iron, cobalt, platinum and palladium in amounts of up to about 3%.
3. The guidewire of claim 1 wherein the alloy contains one or more additional alloying elements selected from the group consisting of copper in amounts of up to 12% and vanadium in amounts of up to about 10%.
4. The guidewire of claim 1 wherein the temperature of the heat treatment is between about 475° and about 550° C.
5. The guidewire of claim 1 wherein the superelastic portion has a straight memory at a temperature less than about 450° C.
6. The guidewire of claim 1 wherein the final cold worked alloy part is mechanically straightened before the heat treatment.
7. A superelastic alloy body having an austenite phase which is stable at a desired operating temperature and which will transform to martensite phase upon the application thereto of stress, exhibiting a recoverable strain of at least about 4% upon the stress induced transformation of the austenite phase to martensite phase and having been formed by thermomechanical processing which includes a final cold working about 10 to about 75% and a memory imparting heat treatment at a temperature between about 475° and about 600° C.
8. The body of claim 7 wherein the strain of the body during the stress induced transformation of the austenite phase to the martensite phase is within the range of about 2% to about 8%.
9. The body of claim 7 wherein the austenite-to-martensite transformation occurs at a relatively constant stress above about 50 ksi.
10. The body of claim 7 wherein the austenite-to-martensite transformation occurs at a relatively constant stress above about 70 ksi.
11. The body of claim 7 wherein a distal portion thereof has a plurality of sections which have progressively smaller cross-sections in the distal direction.
12. The body of claim 7 further comprising a flexible member disposed about the superelastic distal portion thereof.
13. The body of claim 12 wherein the flexible member is a helical coil with a rounded plug on the distal end thereof.
14. The body of claim 6 wherein tension is applied to the elongated body while being subjected to the memory imparting heat treatment.
15. The body of claim 6 wherein the body is subjected to mechanical straightening between the cold working and heat treating steps.
16. A fixed-wire balloon angioplasty catheter comprising:
a) an elongated catheter body with an inner lumen extending therein;
b) an inflatable balloon on the distal extremity of the catheter body and having an interior in fluid communication with the inner lumen of the catheter body; and
c) a guiding member which is disposed at least in part within the interior of the inflatable balloon and which is formed at least in part of a superelastic alloy body having an austenite phase which is stable at a desired operating temperature and which will transform to martensite phase upon the application thereto of stress, exhibiting a recoverable strain of at least about 4% upon the stress induced transformation of the austenite phase to martensite phase and having been formed by a thermomechanical processing which includes a final cold working of about 10 to about 75% and then a memory imparting heat treatment at a temperature between about 450° and about 600° C. while tension is applied thereto.
17. The fixed wire balloon angioplasty catheter of claim 17 wherein the thermomechanical processing includes a mechanical straightening between the cold working and heat treating.
18. A method of forming a superelastic elongated member being in an austenite phase which is stable at temperatures less than about 45° C.:
providing an elongated member formed of an alloy consisting essentially of about 30 to about 52% titanium, about 38 to about 52% nickel and up to a total of about 20% of one or more additional alloying elements selected from the group consisting of iron, cobalt, chromium, platinum, palladium, copper, vanadium, zirconium, hafnium and niobium;
subjecting the elongated member to thermomechanical processing which includes a final cold working of about 10 to about 75% and a heat treatment at a temperature between about 450° and about 600° C. while subjecting the elongated member to a tension of up to about 50% of the room temperature tensile strength.
19. The method of claim 18 wherein the elongated member is subjected to mechanical straightening after the final cold working but before the heat treatment.
20. The method of claim 18 wherein the heat treating temperature is between about 475° and about 550° C.
21. The method of claim 18 wherein the final cold-worked number is heat treated for about 0.5 to about 60 minutes.
22. An elongated tubular body suitable for use within a human body which has a cylindrical wall defining an inner lumen therein, which is formed of a superelastic alloy consisting essentially of about 30 to about 52% titanium, about 38 to 52% nickel, and to about 20% of one or more elements selected from the group consisting of iron, cobalt, chromium, platinum, palladium, copper, vanadium, zirconium, hafnium and niobium in a stable austenite phase which will transform to martensite phase upon the application of stress, which will exhibit a recoverable strain of at least about 4% from the application of stress which transforms the austenite phase to the martensite phase and which has been fabricated by a thermomechanical processing which includes a final cold working of about 10 to about 75% and then a memory imparting heat treatment at a temperature of about 450° to about 600° C.
23. The tubular body of claim 22 wherein the stress level at which the austenite phase transforms to the martensite phase is above 50 ksi.
24. The tubular body of claim 22 wherein the austenite-to-martensite transformation occurs at a relatively constant yield stress above about 70 ksi.
25. The tubular body of claim 22 wherein the alloy contains at least one element selected from the group consisting of up to about 20% copper and up to about 10% vanadium.
26. The tubular body of claim 22 wherein the alloy contains at least one element selected from the group consisting of iron, cobalt, palladium and platinum in amounts up to about 3%.
27. The tubular body of claim 24 having an outer diameter of about 0.006 to about 0.05 inch and a wall thickness of about 0.001 to about 0.004 inch.
28. A method of forming a superelastic elongated member having a straight memory comprising subjecting an elongated member having a composition consisting of a predominant amount of NiTi intermetallic constituent to thermomechanical processing which includes a final cold working of about 10 to about 75% and a heat treatment at a temperature between about 450° and about 600° C. while subjecting the cold worked elongated member to sufficient tension to ensure a straight memory.
29. The method of claim 28 wherein the elongated member is formed of an alloy consisting essentially of about 30 to about 52% titanium, abut 38 to about 52% nickel and up to a total of about 10% of one or more additional alloying elements selected from the group consisting of iron, cobalt, chromium, platinum, palladium, coppers vanadium, zirconium, hafnium and niobium.
30. The method of claim 29 wherein the elongated member is in the austenite phase.
31. The method of claim 29 wherein the heat treatment is at a temperature between about 475° to about 550° C.
32. The method of claim 29 wherein the elongated member is mechanically straightened after the final cold working and before the heat treating.
Descripción
    RELATED APPLICATIONS
  • [0001]
    This application is a continuation-in-part application to application Ser. No. 07/629,381, filed Dec. 18, 1990, entitled SUPERELASTIC GUIDING MEMBER.
  • BACKGROUND OF THE INVENTION
  • [0002]
    This invention relates to the field of medical devices, and more particularly to guiding means such as guidewires for advancing catheters within body lumens in procedures such as percutaneous transluminal coronary angioplasty (PTCA).
  • [0003]
    In typical PTCA procedures a guiding catheter having a preformed distal tip is percutaneously introduced into the cardiovascular system of a patient in a conventional Seldiger technique and advanced therein until the distal tip of the guiding catheter is seated in the ostium of a desired coronary artery. A guidewire is positioned within an inner lumen of a dilatation catheter and then both are advanced through the guiding catheter to the distal end thereof. The guidewire is first advanced out of the distal end of the guiding catheter into the patient's coronary vasculature until the distal end of the guidewire crosses a lesion to be dilated, then the dilatation catheter having an inflatable balloon on the distal portion thereof is advanced into the patient's coronary anatomy over the previously introduced guidewire until the balloon of the dilatation catheter is properly positioned across the lesion. Once in position across the lesion, the balloon is inflated to a predetermined size with radiopaque liquid at relatively high pressures (e.g. greater than 4 atmospheres) to compress the arteriosclerotic plaque of the lesion against the inside of the artery wall and to otherwise expand the inner lumen of the artery. The balloon is then deflated so that blood flow is resumed through the dilated artery and the dilatation catheter can be removed therefrom.
  • [0004]
    Conventional guidewires for angioplasty and other vascular procedures usually comprise an elongated core member with one or more tapered sections near the distal end thereof and a flexible body such as a helical coil disposed about the distal portion of the core member. A shapable member, which may be the distal extremity of the core member or a separate shaping ribbon which is secured to the distal extremity of the core member extends through the flexible body and is secured to a rounded plug at the distal end of the flexible body. Torquing means are provided on the proximal end of the core member to rotate, and thereby steer, the guidewire while it is being advanced through a patient's vascular system.
  • [0005]
    Further details of dilatation catheters, guidewires, and devices associated therewith for angioplasty procedures can be found in U.S. Pat. No. 4,323,071 (Simpson et al.); U.S. Pat. No. 4,439,185 (Lundquist); U.S. Pat. No. 4,516,972 (Samson); U.S. Pat. No. 4,538,622 (Samson et al.); U.S. Pat. No. 4,554,929 (Samson et al.); U.S. Pat. No. 4,616,652 (Simpson); and U.S. Pat. No. 4,638,805 (Powell).
  • [0006]
    Steerable dilatation catheters with fixed, built-in guiding members, such as described in U.S. Pat. No. 4,582,181 (now Re 33,166) are frequently used because they have lower deflated profiles than conventional over-the-wire dilatation catheters and a lower profile allows the catheter to cross tighter lesions and to be advanced much deeper into a patient's coronary anatomy.
  • [0007]
    A major requirement for guidewires and other guiding members, whether they be solid wire or tubular members, is that they have sufficient columnar strength to be pushed through a patient's vascular system or other body lumen without kinking. However, they must also be flexible enough to avoid damaging the blood vessel or other body lumen through which they are advanced. Efforts have been made to improve both the strength and flexibility of guidewires to make them more suitable for their intended uses, but these two properties are for the most part diametrically opposed to one another in that an increase in one usually involves a decrease in the other.
  • [0008]
    The prior art makes reference to the use of alloys such as NITINOL, which is an acronym for Ni-Ti Naval Ordnance Laboratory. These alloys have shape memory and/or superelastic characteristics and may be used in medical devices which are designed to be inserted into a patient's body. The shape memory characteristics allow the devices to be deformed to facilitate their insertion into a body lumen or cavity and then be heated within the body so that the device returns to its original shape. Superelastic characteristics on the other hand generally allow the metal to be deformed and restrained in the deformed condition to facilitate the insertion of the medical device containing the metal into a patient's body, with such deformation causing the phase transformation. Once within the body lumen the restraint on the superelastic member can be removed, thereby reducing the stress therein so that the superelastic member can return to its original undeformed shape by the transformation back to the original phase.
  • [0009]
    Alloys having shape memory/superelastic characteristics generally have at least two phases. These phases are a martensite phase, which has a relatively low tensile strength and which is stable at relatively low temperatures, and an austenite phase, which has a relatively high tensile strength and which is stable at temperatures higher than the martensite phase.
  • [0010]
    Shape memory characteristics are imparted to the alloy by heating the metal at a temperature above which the transformation from the martensite phase to the austenite phase is complete, i.e. a temperature above which the austenite phase is stable. The shape of the metal during this heat treatment is the shape “remembered”. The heat treated metal is cooled to a temperature at which the martensite phase is stable, causing the austenite phase to transform to the martensite phase. The metal in the martensite phase is then plastically deformed, e.g. to facilitate the entry thereof into a patient's body. Subsequent heating of the deformed martensite phase to a temperature above the martensite to austenite transformation temperature causes the deformed martensite phase to transform to the austenite phase and during this phase transformation the metal reverts back to its original shape.
  • [0011]
    The prior methods of using the shape memory characteristics of these alloys in medical devices intended to be placed within a patient's body presented operational difficulties. For example, with shape memory alloys having a stable martensite temperature below body temperature, it was frequently difficult to maintain the temperature of the medical device containing such an alloy sufficiently below body temperature to prevent the transformation of the martensite phase to the austenite phase when the device was being inserted into a patient's body. With intravascular devices formed of shape memory alloys having martensite-to-austenite transformation temperatures well above body temperature, the devices could be introduced into a patient's body with little or no problem, but they had to be heated to the martensite-to-austenite transformation temperature which was frequently high enough to cause tissue damage and very high levels of pain.
  • [0012]
    When stress is applied to a specimen of a metal such as NITINOL exhibiting superelastic characteristics at a temperature above which the austenite is stable (i.e. the temperature at which the transformation of martensite phase to the austenite phase is complete), the specimen deforms elastically until it reaches a particular stress level where the alloy then undergoes a stress-induced phase transformation from the austenite phase to the martensite phase. As the phase transformation proceeds, the alloy undergoes significant increases in strain but with little or no corresponding increases in stress. The strain increases while the stress remains essentially constant until the transformation of the austenite phase to the martensite phase is complete. Thereafter, further increase in stress are necessary to cause further deformation. The martensitic metal first yields elastically upon the application of additional stress and then plastically with permanent residual deformation.
  • [0013]
    If the load on the specimen is removed before any permanent deformation has occurred, the martensitic specimen will elastically recover and transform back to the austenite phase. The reduction in stress first causes a decrease in strain. As stress reduction reaches the level at which the martensite phase transforms back into the austenite phase, the stress level in the specimen will remain essentially constant (but substantially less than the constant stress level at which the austenite transforms to the martensite) until the transformation back to the austenite phase is complete, i.e. there is significant recovery in strain with only negligible corresponding stress reduction. After the transformation back to austenite is complete, further stress reduction results in elastic strain reduction. This ability to incur significant strain at relatively constant stress upon the application of a load and to recover from the deformation upon the removal of the load is commonly referred to as superelasticity or pseudoelasticity.
  • [0014]
    The prior art makes reference to the use of metal alloys having superelastic characteristics in medical devices which are intended to be inserted or otherwise used within a patient's body. See for example, U.S. Pat. No. 4,665,905 (Jervis) and U.S. Pat. No. 4,925,445 (Sakamoto et al.).
  • [0015]
    The Sakamoto et al. patent discloses the use of a nickel-titanium superelastic alloy in an intravascular guidewire which could be processed to develop relatively high yield strength levels. However, at the relatively high yield stress levels which cause the austenite-to-martensite phase transformation characteristic of the material, it did not have a very extensive stress-induced strain range in which the austenite transforms to martensite at relative constant stress. As a result, frequently as the guidewire was being advanced through a patient's tortuous vascular system, it would be stressed beyond the superelastic region, i.e. develop a permanent set or even kink which can result in tissue damage. This permanent deformation would generally require the removal of the guidewire and the replacement thereof with another.
  • [0016]
    Products of the Jervis patent on the other hand had extensive strain ranges, i.e. 2 to 8% strain, but the relatively constant stress level at which the austenite transformed to martensite was very low, e.g. 50 ksi.
  • [0017]
    What has been needed and heretofore unavailable is an elongated solid or tubular body for intravascular devices, such as guide wires or guiding members, which have at least a portion thereof exhibiting superelastic characteristics including an extended strain region over a relatively constant high stress level which effects the austenite transformation to martensite and still provide a one-to-one torque response. The present invention satisfies these and other needs.
  • SUMMARY OF THE INVENTION
  • [0018]
    The present invention is directed to an improved superelastic body which is suitable for intraluminal devices, such as guidewires or guiding members, wherein superelastic characteristics result from the stress-induced transformation of austenite to martensite.
  • [0019]
    The superelastic alloy body of the invention has a stable austenite phase which will transform to martensite phase upon the application of stress and will exhibit a recoverable strain of at least about 4% upon the stress induced transformation of the austenite phase to the martensite phase. The formation of the alloy body includes a final cold working about 10 to about 75% and then a final memory imparting heat treatment at a temperature of about 450° to about 600° C., preferably 475° to about 550° C. The cold worked, heat treated product exhibits a stress-induced phase transformation at temperatures below about 450° C. at a relatively high stress level, e.g. above about 70 ksi, (483 Mpa) preferably above about 90 ksi (620 Mpa) for solid products and about 40 ksi (276 Mpa) for hollow tubular products. The superelastic product exhibits at recoverable strain of at least 4% upon completion of the stress-induced transformation of the austenite phase to the martensite phase. The onset of the stress induced phase change from austenite to martensite, preferably begins when the specimen has been strained about 2% and extends to a strain level of about 8% at the completion of the phase change. The stress and strain referred to herein is measured by tensile testing. The stress-strain relationship determined by applying a bending moment to a cantilevered specimen is slightly different from the relationship determined by tensile testing because the stresses which occur in the specimen during bending are not as uniform as they are in tensile testing. The stress change during the phase transformation is much less than the stress either before or after the stress-induced transformation. In some instances the stress level during the phase change is almost constant.
  • [0020]
    The elongated portion of the guiding member having superelastic properties is preferably formed from an alloy consisting essentially of about 30 to about 52% titanium, about 38% to about 52% nickel and additional alloying elements in amount up to 20% for copper and up to about 10% in the case of other alloying elements. The additional alloying elements may be selected from the group consisting of up to 3% each of iron, cobalt, chromium, platinum, palladium, zirconium, hafnium and niobium and up to about 10% vanadium. At nickel levels above 52% the alloy becomes too brittle to fabricate by cold working. Metallurgically the alloy consist essentially of a predominant quantity of a NiTi intermetallic compound and small quantities of other constituents. Additionally, when nickel is in excess Ni3Ti is formed, whereas when titanium is in excess Ti2Ni is formed. As used herein, all references to percent alloy compositions are atomic percent unless otherwise noted.
  • [0021]
    To form the elongated superelastic portion of the guiding member, elongated solid rod or tubular stock of the preferred alloy material is first thermomechanically processed through a series of cold working, e.g. drawing and inter-annealing at temperatures between about 600° to about 800° C. for about 5 to about 30 minutes and is then given a final cold working, e.g. drawing, to effect a final size reduction of about 10% up to about 75% in the transverse cross section thereof. For solid products the final cold work is preferably about 30 to about 70% and for hollow tubular products the final cold work is preferably about 10% to about 40%. As used herein % cold work is the size reduction of the transverse dimension of the work piece effected by the cold working. After the final cold working, the material is given a heat treatment at a temperature of about 450° to about 600° C., preferably about 475° to about 550° C., for about 0.5 to about 60 minutes to generate the superelastic properties. To impart a straight memory, the cold worked material may be subjected to a longitudinal stress equal to about 5% to about 50%, preferably about 10% to about 30%, of the yield stress of the material (as measured at room temperature) during a heat treatment of about 450° to about 600° C. This thermomechanical processing imparts a straight “memory” to the superelastic portion and provides a relatively uniform residual stress in the material. Preferably, the final cold worked product is subjected to mechanically straightening between the final cold working and heat treating steps to provide the wire or tubular product with substantially improved, one-to-one torque response, i.e. it is substantially whip free. The alloy composition and thermal treatment are selected to provide an austenite finish transformation temperature generally about −20° to about 400° C. and usually less than body temperature (approx. 37° C.). To obtain more consistent final properties, it is preferred to fully anneal the solid rod or tubular stock prior to cold working so that the material will always have the same metallurgical structure at the start of the cold working. The pre-annealing also ensures adequate ductility for cold working. It will be appreciated by those skilled in the art that the alloy can be cold worked in a variety of ways other than drawing, such as rolling or swaging. The constant stress levels for tubular products have been found to be slightly lower than the constant stress levels for solid products due to the inability to cold work the tubular products to the extent the solid products can be cold worked. For example, solid superelastic wire material of the invention can have a relatively constant stress level above about 70 ksi, usually above about 90 ksi, whereas, hollow superelastic tubing material of the invention can have a relatively constant stress level above about 50 ksi (345 Mpa) usually above about 60 ksi (414 Mpa). The ultimate tensile strength of both forms of the material is well above 200 ksi (1380 Mpa) with an ultimate elongation at failure of about 15%.
  • [0022]
    The elongated body of the invention exhibits a stress-induced austenite-to-martensite phase transformation over a broad region of strain at very high, relatively constant stress levels. As a result a guiding member formed of this material is very flexible, it can be advanced through very tortuous passageways such as a patient's coronary vasculature with little risk that the superelastic portion of the guiding member will develop a permanent set and at the same time it will effectively transmit the torque applied thereto without causing the guiding member to whip.
  • [0023]
    These and other advantages of the invention will become more apparent from the following detailed description thereof when taken in conjunction with the following exemplary drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0024]
    [0024]FIG. 1 illustrates a guidewire which embodies features of the invention.
  • [0025]
    [0025]FIG. 2 illustrates another embodiment of a guidewire of the invention.
  • [0026]
    [0026]FIG. 3 is a partial side elevational view, partially in section, of a guiding member embodying features of the invention which is incorporated into a fixed-wire dilatation catheter adapted for balloon angioplasty procedures.
  • [0027]
    [0027]FIG. 4 is a schematic, graphical illustration of the stress-strain relationship of superelastic material.
  • [0028]
    [0028]FIG. 5 illustrates another embodiment of a guidewire embodying features of the invention.
  • [0029]
    [0029]FIG. 6 illustrates the effects of the temperature during heat treatment after final cold working on the final austenite transformation temperature (Af).
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0030]
    [0030]FIG. 1 illustrates a guidewire 10 embodying features of the invention that is adapted to be inserted into a body lumen such as an artery. The guidewire 10 comprises an elongated body or core member 11 having an elongated proximal portion 12 and a distal portion 13, at least part of which, preferably the distal portion, is formed of superelastic material of the invention. The distal portion 13 has a plurality of sections 14, 15 and 16 having sequentially smaller diameters with tapered sections 17, 18 and 19 connecting the smaller diameter sections with adjacent sections. The elongated proximal portion 12 is provided with a female distal end 20 which receives the male end 21 of the distal portion 13. The ends 20 and 21 may be press fit together or may be secured together by means such as a suitable adhesive or by welding, brazing or soldering.
  • [0031]
    A helical coil 22 is disposed about the distal portion 13 and has a rounded plug 23 on the distal end thereof where the distal end of the helical coil is welded to the distal end of a shaping ribbon 24 which is secured by its proximal end to the distal portion 13 by suitable means (e.g. brazing) at location 25. The coil 22 is also secured to the distal portion 13 of the elongated body 11 at location 25 and to the tapered section 17 at location 26. Preferably, the most distal section 27 of the helical coil 22 is made of radiopaque metal such as platinum or alloys thereof to facilitate the fluoroscopic observation of the distal portion of the guidewire while it is disposed within a patient's body.
  • [0032]
    The exposed portion of the elongated body 11 should be provided with a coating 28 of lubricous material such as polytetrafluoroethylene (sold under the trademark Teflon by du Pont) or other suitable lubricous coatings such as the polysiloxane coatings disclosed in copending application Ser. No. 559,373, filed Jul. 24, 1990 which is hereby incorporated by reference.
  • [0033]
    [0033]FIG. 2 illustrates another embodiment of a guidewire which incorporates features of the invention. This embodiment is very similar to the embodiment shown in FIG. 1 except that the entire elongated body 11 is formed of material having superelastic characteristics and the distal portion 13 of the core member 11 extends all the way to the plug 23 and is preferably flattened at its most distal extremity 29 as ribbon 24 in the embodiment shown in FIG. 1. All of the parts of the guidewire shown in FIG. 2 which correspond to the parts shown in FIG. 1 are numbered the same as in FIG. 1.
  • [0034]
    [0034]FIG. 3 illustrates a fixed wire, steerable dilatation catheter 40 which has incorporated therein a guiding member 41 in accordance with the invention. In this embodiment, the catheter 40 includes an elongated tubular member 42 having an inner lumen 43 extending therein and an inflatable, relatively inelastic dilatation balloon 44 on the distal extremity of the tubular member. Guiding member 41 which includes an elongated body 45, a helical coil 46 disposed about and secured to the distal end of the elongated body 45 and a shaping ribbon 50 extending from the distal end of the elongated body to rounded plug 51 at the distal end of the coil 46. The proximal portion 52 of the elongated body 45 is disposed within the inner lumen 43 of the tubular member 42 and the distal portion 53 of the elongated body 45 extends through the interior of the dilatation balloon 44 and out the distal end thereof. The distal end of the balloon 44 is twisted and sealed about the distal portion 53 of the elongated body 45 extending therethrough in a manner which is described in more detail in copending application Ser. No. 521,103, filed May 9, 1990, which is hereby incorporated by reference. The helical coil 46 is secured to the distal portion 53 of the elongated body 45 by suitable means such as brazing at location 54 which is the same location at which the shaping ribbon 50 is secured to the distal portion of the elongated body. Preferably, the distal portion 53 is free to rotate within the twisted seal of the distal end of the balloon 44 and means are provided to seal the distal portion 53 therein to allow air to be vented therethrough but not inflation fluid such as shown in U.S. Pat. No. 4,793,350 (Mar et al.). The proximal end of the catheter 40 is provided with a multiple arm adapter 55 which has one arm 56 for directing inflation fluid through the inner lumen 43 and the interior of the balloon 44. The proximal end of the elongated body 45 extends through the adapter 55 and is secured to the torquing handle 57 which rotates the guiding member 41 within the catheter 40 as the catheter is advanced through a patient's vascular system. The tubular member 42 may be formed of suitable plastic material such as polyethylene or polyamide or metals such as stainless steel or NITINOL. All or at least the distal portion of the tubular member 42 may be formed of the superelastic NiTi type alloy material of the invention. In an alternative construction, the elongated body 45 has a flattened distal portion which is secured to the rounded plug 51.
  • [0035]
    The elongated body 11 of the guidewire 10 and elongated body 45 of the fixed-wire catheter 40 are generally about 150 to about 200 cm (typically about 175 cm) in length with an outer diameter of about 0.01 to 0.018 inch (0.25-0.46 mm) for coronary use. Larger diameter guidewire and guiding members may be employed in peripheral arteries. The lengths of the smaller diameter sections 14, 15 and 16 can range from about 5 to about 30 cm. The tapered sections 17, 18 and 19 generally are about 3 cm in length, but these too can have various lengths depending upon the stiffness or flexibility desired in the final product. The helical coils 22 and 46 are about 20 to about 40 cm in length, have an outer diameter about the same size as the diameter of the elongated bodies 11 and 45, and are made from wire about 0.002 to 0.003 inch (0.051-0.076 mm) in diameter. The last or most distal 1.5 to about 4 cm of the coil is longitudinally expanded and preferably made of platinum or other radiopaque material to facilitate the fluoroscopic observation thereof when the guidewire or fixed wire catheter is inserted into a patient. The remaining portion of the coils 22 and 45 may be stainless steel. The transverse cross-section of the elongated bodies 11 and 45 is generally circular. However, the shaping ribbons 24 and 50 and the flattened distal section 29 have rectangular transverse cross-sections which usually have dimensions of about 0.001 by 0.003 inch (0.025-0.076 mm).
  • [0036]
    The superelastic guiding member of the invention, whether it is the entire elongated body 11 or 45 or just a portion thereof, is preferably made of an alloy material consisting essentially of about 30 to about 52% titanium, about 38 to 50% nickel and the balance one or more additional alloying elements in amounts of up to about 20%, preferably up to about 12% in the case of copper and up to 10% for other additional alloying elements. The other additional alloying elements may be selected from the group consisting of iron, cobalt, platinum, palladium, zirconium, hafnium and niobium in amounts up to 3% each and vanadium in an amount of up to 10%. The addition of nickel above equiatomic amounts with titanium and the other identified alloying elements increases the stress levels at which the stress-induced austenite-to-martensite transformation occurs and ensures that the temperature at which the martensite phase transforms to the austenite phase is well below human body temperature so that austenite is the only stable phase at body temperature. The excess nickel and additional alloying elements also help to provide an expanded strain range at very high stresses when the stress induced transformation of the austenite phase to the martensite phase occurs.
  • [0037]
    A presently preferred method for making the final configuration of the superelastic portion of the guiding member is to cold work, preferably by drawing, a rod or tubular member having a composition according to the relative proportions described above to effect a final size reduction of about 10 to about 75% and then providing a memory imparting heat treatment to the cold worked product at a temperature of about 450° to about 600° C. preferably about 475° to about 550° C., for about 0.5 to about 60 minutes. In one preferred embodiment the cold worked product is subjected to tensile stress to hold the product straight during the heat treatment to impart a straight memory thereto. In the embodiment with a solid wire product, the final cold work preferably ranges from about 30 to about 70% and the heat treatment temperature ranges from about 450° to about 600° C., preferably about 475° to about 550° C. In another presently preferred embodiment with tubular products, the final cold work ranges from about 10 to about 40% and the final memory imparting heat treatment temperature ranges are the same as mentioned above. Typical initial transverse dimensions of the rod or the tubular member prior to cold working are about 0.045 inch (1.14 mm) and about 0.25 inch (6.35 mm) respectively. If the final product is to be a tubular product, a small diameter ingot, e.g. 0.20 to about 1.5 inch (5.1-38.1 mm) in diameter and 5 to about 48 inches (12.7-122 cm) in length, may be formed into a hollow tube by extruding or by machining a longitudinal center hole through a solid rod and grinding the outer surface thereof smooth.
  • [0038]
    After each drawing step, except the last, the solid rod or tubular member is preferably annealed at a temperature of about 600° to about 800° C., typically about 675° C., for about 15 minutes in air or a protective atmosphere such as argon to relieve essentially all internal stresses. In this manner all of the specimens start the subsequent thermomechanical processing in essentially the same metallurgical condition so that consistent final properties are obtained. Such treatment also provides the requisite ductility for effective subsequent cold working. The stress relieved stock is preferably drawn through one or more dies of appropriate inner diameter with a reduction per pass of about 10 to 70%. The final heat treatment fixes the austenite-martensite transformation temperature. Mechanical straightening prior to the final heat treatment, particularly when tension is applied during the last heat treatment ensures a uniform level of residual stresses throughout the length of the superelastic material which minimizes or eliminates guidewire whipping when made of this material when torqued within a patient's blood vessel.
  • [0039]
    In a typical procedure, starting with solid rod stock 0.100 inch (2.54 mm) in diameter, the cold working/heat treatment schedule would be performed as follows:
  • [0040]
    1. Cold work 60% from 0.100 inch to 0.0632 inch (1.61 mm) and anneal at 675° C. for 15 minutes.
  • [0041]
    2. Cold work 60% form 0.0632 inch to 0.0399 inch (1.02 mm) and anneal at 675° C. for 15 minutes.
  • [0042]
    3. Cold work 60% by drawing through 2-3 dies from 0.0399 inch to 0.0252 inch (0.64 mm) and anneal at 675° C. for 15 minutes.
  • [0043]
    5. Cold work 69% by drawing through 2-3 dies from 0.0252 inch to 0.014 inch (0.36 mm).
  • [0044]
    6. Mechanically straighten and then continuously heat treat at 510° C. at 1 ft/min (0.0305 m/min) under sufficient tension to impart a straight memory.
  • [0045]
    When the cold worked material is subjected to the slightly lower thermal treatments, it has substantially higher tensile properties and it exhibits stress-induced austenite to martensite phase transformation at very high levels of stress but the stress during the phase transformation is not very constant. The addition of mechanical straightening prior to the final memory imparting heat treatment under tension will substantially improve the whipping characteristics of the final product.
  • [0046]
    [0046]FIG. 4 illustrates an idealized stress-strain relationship of an alloy specimen having superelastic properties as would be exhibited upon tensile testing of the specimen. The line from point A to point B thereon represents the elastic deformation of the specimen. After point B the strain or deformation is no longer proportional to the applied stress and it is in the region between point, B and point C that the stress-induced transformation of the austenite phase to the martensite phase begins to occur. There can be an intermediate phase developed, sometimes called the rhombohedral phase, depending upon the composition of the alloy. At point C the material enters a region of relatively constant stress with significant deformation or strain. It is in the region of point C to point D that the transformation from austenite to martensite occurs. At point D the stress induced transformation to the martensite phase is substantially complete. Beyond point D the stress-induced martensite phase begins to deform, elastically at first, but, beyond point E, the deformation is plastic or permanent. If plastic deformation occurs, the strain will not return to zero upon the removal of the stress.
  • [0047]
    When the stress applied to the superelastic metal is removed, the metal will recover to its original shape, provided that there was no permanent deformation to the martensite phase. At point F in the recovery process, the metal begins to transform from the stress-induced, unstable martensite phase back to the more stable austenite phase. In the region from point G to point H, which is also an essentially constant stress region, the phase transformation from martensite back to austenite is essentially complete. The line from point I to the starting point A represents the elastic recovery of the metal to its original shape.
  • [0048]
    [0048]FIG. 5 illustrates a guidewire 60 embodying features of the invention which comprises an elongated, relatively high strength proximal portion 61, a relatively short distal portion 62 which is formed substantially of superelastic alloy material and a tubular connector element 63 which is formed substantially of superelastic alloy material and which connects the proximal end of the distal portion 62 to the distal end of the proximal portion 61 into a torque transmitting relationship. The distal portion 62 has at least one tapered section 64 which becomes smaller in the distal direction. The connector element 63 is a hollow tubular shaped element having an inner lumen extending therein which is adapted to receive the proximal end 65 of the distal portion 62 and the distal end 66 of the proximal portion 61. The ends 65 and 66 may be press fit into the connector element 63 or they may be secured therein by crimping or swaging the connector element or by means such as a suitable adhesive or by welding, brazing or soldering.
  • [0049]
    A helical coil 67 is disposed about the distal portion 62 and has a rounded plug 68 on the distal end thereof. The coil 67 is secured to the distal portion 62 at proximal location 70 and at intermediate location 71 by a suitable solder. A shaping ribbon 72 is secured by its proximal end to the distal portion 62 at the same location 71 by the solder and by the distal end thereof to the rounded plug 68 which is usually formed by soldering or welding the distal end of the coil 67 to the distal tip of the shaping ribbon 72. Preferably, the distal section 74 of the helical coil 67 is made of radiopaque metal such as platinum or platinum-nickel alloys to facilitate the observation thereof while it is disposed within a patient's body. The distal section 74 should be stretched about 10 to about 30%.
  • [0050]
    The most distal part 75 of the distal portion 62 is flattened into a rectangular section and preferably provided with a rounded tip 76, e.g. solder, to prevent the passage of the most distal part through the spacing between the stretched distal section 74 of the helical coil 67.
  • [0051]
    The exposed portion of the elongated proximal portion 61 should be provided with a coating 77 of lubricous material such as polytetrafluoroethylene (sold under the trademark Teflon by du Pont, de Nemours & Co.) or other suitable lubricous coatings such as the polysiloxane coatings disclosed in co-pending application Ser. No. 559,373, filed Jul. 24, 1990 which is hereby incorporated by reference.
  • [0052]
    The elongated proximal portions of the guidewires of the invention for coronary use are generally about 130 to about 140 cm in length with outer diameters of about 0.006 to 0.018 inch (0.152-0.457 mm). Larger diameter guidewires may be employed in peripheral arteries and other body lumens. The lengths of the smaller diameter and tapered sections can range from about 2 to about 20 cm, depending upon the stiffness or flexibility desired in the final product. The helical coils are about 20 to about 45 cm in length, have an outer diameter about the same size as the diameter of the elongated proximal portions, and are made from wire about 0.002 to 0.003 inch in diameter. The shaping ribbons and the flattened distal sections of the distal portions have rectangular transverse cross-sections which usually have dimensions of about 0.001 by 0.003 inch.
  • [0053]
    An important feature of the present invention is the capability of maintaining the level of the yield stress which effects the stress induced austenite-to-martensite transformation as high as possible, e.g. above 70 ksi, preferably above 90 ksi for solid products (lower with tubular products), with an extensive region of recoverable strain, e.g. a strain range of at least 4%, preferably at least 5%, which occurs during the phase transformation particularly at relatively constant stress.
  • [0054]
    [0054]FIG. 6 graphically illustrates the relationship of the final austenite transformation temperature (Af) of a binary NiTi alloy of the invention with the temperature to which the alloy is subjected during the heat treatment. The amount of cold work and composition will shift the curve to the other valves but will not change the general shape of the curve.
  • [0055]
    Because of the extended strain range under stress-induced phase transformation which is characteristic of the superelastic material described herein, a guidewire made at least in part of such material can be readily advanced through tortuous arterial passageways. When the guidewire or guiding member of the invention engages the wall of a body lumen such as a blood vessel, it will deform and in doing so will transform the austenite of the superelastic portion to martensite. Upon the disengagement of the guidewire or guiding member, the stress is reduced or eliminated from within the superelastic portion of the guidewire or guiding member and it recovers to its original shape, i.e. the shape “remembered” which is preferably straight. The straight “memory” in conjunction with little or no nonuniform residual stresses within the guidewire or guiding member prevent whipping of the guidewire when it is torqued from the proximal end thereof. Moreover, due to the very high level of stress needed to transform the austenite phase to the martensite phase, there is little chance for permanent deformation of the guidewire or the guiding member when it is advanced through a patient's artery.
  • [0056]
    The present invention provides guiding members for guidewires and fixed wire catheters which have superelastic characteristics to facilitate the advancing thereof in a body lumen. The guiding members exhibit extensive, recoverable strain resulting from stress induced phase transformation of austenite to martensite at exceptionally high stress levels which greatly minimizes the risk of damage to arteries during the advancement therein.
  • [0057]
    The superelastic tubular members of the present invention are particularly attractive for use in a wide variety of intravascular catheters, such as fixed-wire catheters wherein the Nitinol hypotubing having superelastic properties may be employed to direct inflation fluid to the interior of the dilatation balloon. In this case a guiding member may be secured to the distal end of the superelastic Nitinol tubing and extend through the interior of the inflatable balloon and out the distal end thereof. The guiding member may also be made of the superelastic Nitinol of the invention.
  • [0058]
    Superelastic hypotubing generally has been found to have a slightly lower stress level compared to wire when the austenite is transformed to martensite. However, this stress level is above 40 ksi and is usually above 70 ksi. The hypotubing of the invention generally may have an outer diameter from about 0.05 inch down to about 0.006 inch (1.27-0.152 mm) with wall thicknesses of about 0.001 to about 0.004 inch. (0.0254-0.102 mm) A presently preferred superelastic hypotubing has an outer diameter of about 0.012 inch (0.31 mm) and a wall thickness of about 0.002 inch (0.051 mm).
  • [0059]
    While the above description of the invention is directed to presently preferred embodiments, various modifications and improvements can be made to the invention without departing therefrom.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US4565589 *28 Sep 198321 Ene 1986Raychem CorporationNickel/titanium/copper shape memory alloy
US4770725 *5 Jun 198713 Sep 1988Raychem CorporationNickel/titanium/niobium shape memory alloy & article
US5108523 *24 Jul 199028 Abr 1992Fried. Krupp GmbhShape memory alloy
US5611874 *26 Jul 199518 Mar 1997Surface Genesis, Inc.Clad shape memory alloy composite structure and method
US20020082681 *27 Dic 200027 Jun 2002Boylan John F.Radiopaque nitinol alloys for medical devices
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US724431911 Nov 200217 Jul 2007Abbott Cardiovascular Systems Inc.Superelastic guiding member
US727607830 Jun 20042 Oct 2007Edwards Lifesciences PvtParavalvular leak detection, sealing, and prevention
US762880529 Ago 20078 Dic 2009Edwards Lifesciences Pvt, Inc.Paravalvular leak detection, sealing and prevention
US768239030 Jul 200223 Mar 2010Medtronic, Inc.Assembly for setting a valve prosthesis in a corporeal duct
US77586065 Feb 200420 Jul 2010Medtronic, Inc.Intravascular filter with debris entrapment mechanism
US778072313 Jun 200524 Ago 2010Edwards Lifesciences CorporationHeart valve delivery system
US778072627 Jul 200724 Ago 2010Medtronic, Inc.Assembly for placing a prosthetic valve in a duct in the body
US787143615 Feb 200818 Ene 2011Medtronic, Inc.Replacement prosthetic heart valves and methods of implantation
US78922815 Ene 200922 Feb 2011Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US791456913 May 200529 Mar 2011Medtronics Corevalve LlcHeart valve prosthesis and methods of manufacture and use
US791801110 Oct 20075 Abr 2011Abbott Cardiovascular Systems, Inc.Method for providing radiopaque nitinol alloys for medical devices
US79388439 Jun 200310 May 2011Abbott Cardiovascular Systems Inc.Devices configured from heat shaped, strain hardened nickel-titanium
US79428921 May 200317 May 2011Abbott Cardiovascular Systems Inc.Radiopaque nitinol embolic protection frame
US797237823 Ene 20095 Jul 2011Medtronic, Inc.Stents for prosthetic heart valves
US79766482 Nov 200012 Jul 2011Abbott Cardiovascular Systems Inc.Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite
US800282614 Oct 200923 Ago 2011Medtronic Corevalve LlcAssembly for placing a prosthetic valve in a duct in the body
US801687729 Jun 200913 Sep 2011Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US805275023 Mar 20078 Nov 2011Medtronic Ventor Technologies LtdValve prosthesis fixation techniques using sandwiching
US807080123 Feb 20096 Dic 2011Medtronic, Inc.Method and apparatus for resecting and replacing an aortic valve
US807561528 Mar 200713 Dic 2011Medtronic, Inc.Prosthetic cardiac valve formed from pericardium material and methods of making same
US809248714 Jun 201010 Ene 2012Medtronic, Inc.Intravascular filter with debris entrapment mechanism
US810999625 Feb 20057 Feb 2012Sorin Biomedica Cardio, S.R.L.Minimally-invasive cardiac-valve prosthesis
US813739813 Oct 200820 Mar 2012Medtronic Ventor Technologies LtdProsthetic valve having tapered tip when compressed for delivery
US815294128 Oct 201010 Abr 2012Saes Smart MaterialsNi-Ti semi-finished products and related methods
US815785222 Ene 200917 Abr 2012Medtronic, Inc.Delivery systems and methods of implantation for prosthetic heart valves
US815785322 Ene 200917 Abr 2012Medtronic, Inc.Delivery systems and methods of implantation for prosthetic heart valves
US816793218 Oct 20051 May 2012Edwards Lifesciences CorporationHeart valve delivery system with valve catheter
US818252823 Dic 200322 May 2012Sadra Medical, Inc.Locking heart valve anchor
US822671025 Mar 201124 Jul 2012Medtronic Corevalve, Inc.Heart valve prosthesis and methods of manufacture and use
US82316703 Nov 200831 Jul 2012Sadra Medical, Inc.Repositionable heart valve and method
US824127430 Sep 200914 Ago 2012Medtronic, Inc.Method for guiding a medical device
US82466789 Mar 200721 Ago 2012Sadra Medicl, Inc.Methods and apparatus for endovascularly replacing a patient's heart valve
US82520528 Feb 200828 Ago 2012Sadra Medical, Inc.Methods and apparatus for endovascularly replacing a patient's heart valve
US831352518 Mar 200820 Nov 2012Medtronic Ventor Technologies, Ltd.Valve suturing and implantation procedures
US832886813 Oct 200911 Dic 2012Sadra Medical, Inc.Medical devices and delivery systems for delivering medical devices
US834321321 Oct 20041 Ene 2013Sadra Medical, Inc.Leaflet engagement elements and methods for use thereof
US834899523 Mar 20078 Ene 2013Medtronic Ventor Technologies, Ltd.Axial-force fixation member for valve
US834899623 Mar 20078 Ene 2013Medtronic Ventor Technologies Ltd.Valve prosthesis implantation techniques
US838282612 Ago 201026 Feb 2013Edwards Lifesciences CorporationMethod of delivering a prosthetic heart valve
US841464323 Mar 20079 Abr 2013Medtronic Ventor Technologies Ltd.Sinus-engaging valve fixation member
US84309272 Feb 200930 Abr 2013Medtronic, Inc.Multiple orifice implantable heart valve and methods of implantation
US850662013 Nov 200913 Ago 2013Medtronic, Inc.Prosthetic cardiac and venous valves
US851239727 Abr 200920 Ago 2013Sorin Group Italia S.R.L.Prosthetic vascular conduit
US853537316 Jun 200817 Sep 2013Sorin Group Italia S.R.L.Minimally-invasive cardiac-valve prosthesis
US853966216 Jun 200824 Sep 2013Sorin Group Italia S.R.L.Cardiac-valve prosthesis
US854076830 Dic 201124 Sep 2013Sorin Group Italia S.R.L.Cardiac valve prosthesis
US856267218 Nov 200522 Oct 2013Medtronic, Inc.Apparatus for treatment of cardiac valves and method of its manufacture
US856847210 Sep 200729 Oct 2013Edwards Lifesciences CorporationIntegrated heart valve delivery system
US857996220 Dic 200512 Nov 2013Sadra Medical, Inc.Methods and apparatus for performing valvuloplasty
US85799664 Feb 200412 Nov 2013Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US859157014 Mar 200826 Nov 2013Medtronic, Inc.Prosthetic heart valve for replacing previously implanted heart valve
US860315911 Dic 200910 Dic 2013Medtronic Corevalve, LlcProsthetic valve for transluminal delivery
US860316023 Dic 200310 Dic 2013Sadra Medical, Inc.Method of using a retrievable heart valve anchor with a sheath
US86137657 Jul 201124 Dic 2013Medtronic, Inc.Prosthetic heart valve systems
US86172362 Nov 201131 Dic 2013Sadra Medical, Inc.Medical devices and delivery systems for delivering medical devices
US862307622 Sep 20117 Ene 2014Sadra Medical, Inc.Low profile heart valve and delivery system
US86230775 Dic 20117 Ene 2014Medtronic, Inc.Apparatus for replacing a cardiac valve
US86230788 Jun 20117 Ene 2014Sadra Medical, Inc.Replacement valve and anchor
US862857018 Ago 201114 Ene 2014Medtronic Corevalve LlcAssembly for placing a prosthetic valve in a duct in the body
US865220430 Jul 201018 Feb 2014Medtronic, Inc.Transcatheter valve with torsion spring fixation and related systems and methods
US866873312 Nov 200811 Mar 2014Sadra Medical, Inc.Everting heart valve
US867300020 May 201118 Mar 2014Medtronic, Inc.Stents for prosthetic heart valves
US868507714 Mar 20121 Abr 2014Medtronics, Inc.Delivery systems and methods of implantation for prosthetic heart valves
US868508428 Dic 20121 Abr 2014Sorin Group Italia S.R.L.Prosthetic vascular conduit and assembly method
US872170823 Sep 201113 May 2014Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US872171323 Abr 200213 May 2014Medtronic, Inc.System for implanting a replacement valve
US872171417 Sep 200813 May 2014Medtronic Corevalve LlcDelivery system for deployment of medical devices
US874745820 Ago 200710 Jun 2014Medtronic Ventor Technologies Ltd.Stent loading tool and method for use thereof
US87474596 Dic 200710 Jun 2014Medtronic Corevalve LlcSystem and method for transapical delivery of an annulus anchored self-expanding valve
US874746023 Dic 201110 Jun 2014Medtronic Ventor Technologies Ltd.Methods for implanting a valve prothesis
US87713026 Abr 20078 Jul 2014Medtronic, Inc.Method and apparatus for resecting and replacing an aortic valve
US877134531 Oct 20118 Jul 2014Medtronic Ventor Technologies Ltd.Valve prosthesis fixation techniques using sandwiching
US877134625 Jul 20118 Jul 2014Medtronic Ventor Technologies Ltd.Valve prosthetic fixation techniques using sandwiching
US877798023 Dic 201115 Jul 2014Medtronic, Inc.Intravascular filter with debris entrapment mechanism
US878447816 Oct 200722 Jul 2014Medtronic Corevalve, Inc.Transapical delivery system with ventruculo-arterial overlfow bypass
US880177910 May 201112 Ago 2014Medtronic Corevalve, LlcProsthetic valve for transluminal delivery
US88083695 Oct 201019 Ago 2014Mayo Foundation For Medical Education And ResearchMinimally invasive aortic valve replacement
US882807820 Sep 20059 Sep 2014Sadra Medical, Inc.Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US883456316 Dic 200916 Sep 2014Sorin Group Italia S.R.L.Expandable prosthetic valve having anchoring appendages
US883456411 Mar 201016 Sep 2014Medtronic, Inc.Sinus-engaging valve fixation member
US884066113 May 200923 Sep 2014Sorin Group Italia S.R.L.Atraumatic prosthetic heart valve prosthesis
US884066227 Oct 201123 Sep 2014Sadra Medical, Inc.Repositionable heart valve and method
US884066323 Dic 200323 Sep 2014Sadra Medical, Inc.Repositionable heart valve method
US885861912 May 200614 Oct 2014Medtronic, Inc.System and method for implanting a replacement valve
US885862010 Jun 201114 Oct 2014Sadra Medical Inc.Methods and apparatus for endovascularly replacing a heart valve
US887689423 Mar 20074 Nov 2014Medtronic Ventor Technologies Ltd.Leaflet-sensitive valve fixation member
US887689523 Mar 20074 Nov 2014Medtronic Ventor Technologies Ltd.Valve fixation member having engagement arms
US88768967 Dic 20114 Nov 2014Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US889470322 Jun 201125 Nov 2014Sadra Medical, Inc.Systems and methods for delivering a medical implant
US892049221 Ago 201330 Dic 2014Sorin Group Italia S.R.L.Cardiac valve prosthesis
US89512809 Jun 201010 Feb 2015Medtronic, Inc.Cardiac valve procedure methods and devices
US895640214 Sep 201217 Feb 2015Medtronic, Inc.Apparatus for replacing a cardiac valve
US89615935 Dic 201324 Feb 2015Medtronic, Inc.Prosthetic heart valve systems
US898632928 Oct 201324 Mar 2015Medtronic Corevalve LlcMethods for transluminal delivery of prosthetic valves
US898636117 Oct 200824 Mar 2015Medtronic Corevalve, Inc.Delivery system for deployment of medical devices
US899260826 Jun 200931 Mar 2015Sadra Medical, Inc.Everting heart valve
US899897612 Jul 20127 Abr 2015Boston Scientific Scimed, Inc.Coupling system for medical devices
US899897911 Feb 20147 Abr 2015Medtronic Corevalve LlcTranscatheter heart valves
US899898115 Sep 20097 Abr 2015Medtronic, Inc.Prosthetic heart valve having identifiers for aiding in radiographic positioning
US90052734 Abr 200714 Abr 2015Sadra Medical, Inc.Assessing the location and performance of replacement heart valves
US901152113 Dic 201121 Abr 2015Sadra Medical, Inc.Methods and apparatus for endovascularly replacing a patient's heart valve
US906085611 Feb 201423 Jun 2015Medtronic Corevalve LlcTranscatheter heart valves
US906085719 Jun 201223 Jun 2015Medtronic Corevalve LlcHeart valve prosthesis and methods of manufacture and use
US906679920 Ene 201130 Jun 2015Medtronic Corevalve LlcProsthetic valve for transluminal delivery
US907878111 Ene 200614 Jul 2015Medtronic, Inc.Sterile cover for compressible stents used in percutaneous device delivery systems
US908942223 Ene 200928 Jul 2015Medtronic, Inc.Markers for prosthetic heart valves
US91383126 Jun 201422 Sep 2015Medtronic Ventor Technologies Ltd.Valve prostheses
US913831410 Feb 201422 Sep 2015Sorin Group Italia S.R.L.Prosthetic vascular conduit and assembly method
US914935723 Dic 20136 Oct 2015Medtronic CV Luxembourg S.a.r.l.Heart valve assemblies
US914935823 Ene 20096 Oct 2015Medtronic, Inc.Delivery systems for prosthetic heart valves
US916183610 Feb 201220 Oct 2015Sorin Group Italia S.R.L.Sutureless anchoring device for cardiac valve prostheses
US922682624 Feb 20105 Ene 2016Medtronic, Inc.Transcatheter valve structure and methods for valve delivery
US923788614 Abr 200819 Ene 2016Medtronic, Inc.Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US924801720 May 20112 Feb 2016Sorin Group Italia S.R.L.Support device for valve prostheses and corresponding kit
US927799131 Dic 20138 Mar 2016Boston Scientific Scimed, Inc.Low profile heart valve and delivery system
US928928910 Feb 201222 Mar 2016Sorin Group Italia S.R.L.Sutureless anchoring device for cardiac valve prostheses
US929555028 Mar 201429 Mar 2016Medtronic CV Luxembourg S.a.r.l.Methods for delivering a self-expanding valve
US930183416 Oct 20095 Abr 2016Medtronic Ventor Technologies Ltd.Sinus-engaging valve fixation member
US930808523 Sep 201412 Abr 2016Boston Scientific Scimed, Inc.Repositionable heart valve and method
US931588030 Mar 201219 Abr 2016Saes Smart MaterialsNi-Ti semi-finished products and related methods
US932059924 Sep 201426 Abr 2016Boston Scientific Scimed, Inc.Methods and apparatus for endovascularly replacing a heart valve
US933132812 Dic 20113 May 2016Medtronic, Inc.Prosthetic cardiac valve from pericardium material and methods of making same
US933938224 Ene 201417 May 2016Medtronic, Inc.Stents for prosthetic heart valves
US935810611 Nov 20137 Jun 2016Boston Scientific Scimed Inc.Methods and apparatus for performing valvuloplasty
US935811031 Dic 20137 Jun 2016Boston Scientific Scimed, Inc.Medical devices and delivery systems for delivering medical devices
US937042130 Dic 201421 Jun 2016Boston Scientific Scimed, Inc.Medical device handle
US938707112 Sep 201412 Jul 2016Medtronic, Inc.Sinus-engaging valve fixation member
US939311227 Feb 201419 Jul 2016Medtronic Ventor Technologies Ltd.Stent loading tool and method for use thereof
US93931139 Dic 201319 Jul 2016Boston Scientific Scimed Inc.Retrievable heart valve anchor and method
US939311523 Ene 200919 Jul 2016Medtronic, Inc.Delivery systems and methods of implantation for prosthetic heart valves
US941522515 Mar 201316 Ago 2016Cardiac Pacemakers, Inc.Method and apparatus for pacing during revascularization
US948055623 Oct 20131 Nov 2016Medtronic, Inc.Replacement prosthetic heart valve, system and method of implant
US948631319 Nov 20148 Nov 2016Sorin Group Italia S.R.L.Cardiac valve prosthesis
US949832921 Oct 201322 Nov 2016Medtronic, Inc.Apparatus for treatment of cardiac valves and method of its manufacture
US950456412 May 200629 Nov 2016Medtronic Corevalve LlcHeart valve prosthesis and methods of manufacture and use
US950456815 Feb 200829 Nov 2016Medtronic, Inc.Replacement prosthetic heart valves and methods of implantation
US952660915 Jul 200427 Dic 2016Boston Scientific Scimed, Inc.Methods and apparatus for endovascularly replacing a patient's heart valve
US953287225 Nov 20143 Ene 2017Boston Scientific Scimed, Inc.Systems and methods for delivering a medical implant
US953287328 Mar 20143 Ene 2017Medtronic CV Luxembourg S.a.r.l.Methods for deployment of medical devices
US95390881 Oct 200910 Ene 2017Medtronic, Inc.Fixation band for affixing a prosthetic heart valve to tissue
US95390924 Dic 201410 Ene 2017Edwards Lifesciences CorporationHeart valve delivery system with valve catheter
US957919421 Oct 200928 Feb 2017Medtronic ATS Medical, Inc.Anchoring structure with concave landing zone
US958574918 Sep 20147 Mar 2017Boston Scientific Scimed, Inc.Replacement heart valve assembly
US958575021 Abr 20157 Mar 2017Boston Scientific Scimed, Inc.Methods and apparatus for endovascularly replacing a patient's heart valve
US958575417 Dic 20157 Mar 2017Medtronic, Inc.Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US959212012 Ago 201414 Mar 2017Medtronic Ventor Technologies, Ltd.Valve suturing and implantation procedures
US96297182 May 201425 Abr 2017Medtronic, Inc.Valve delivery tool
US964270416 Oct 20099 May 2017Medtronic Ventor Technologies Ltd.Catheter for implanting a valve prosthesis
US964949528 Oct 201516 May 2017Cardiac Pacemakers, Inc.Method and apparatus for pacing during revascularization
US97440352 Oct 201529 Ago 2017Boston Scientific Scimed, Inc.Everting heart valve
US977570412 Mar 20073 Oct 2017Medtronic3F Therapeutics, Inc.Implantable valve prosthesis
US978894227 Ene 201617 Oct 2017Boston Scientific Scimed Inc.Prosthetic heart valve having tubular seal
US20030127158 *11 Nov 200210 Jul 2003Abrams Robert M.Superelastic guiding member
US20030199920 *9 Jun 200323 Oct 2003Boylan John F.Devices configured from heat shaped, strain hardened nickel-titanium
US20040220608 *1 May 20034 Nov 2004D'aquanni PeterRadiopaque nitinol embolic protection frame
US20060004442 *30 Jun 20045 Ene 2006Benjamin SpenserParavalvular leak detection, sealing, and prevention
US20060212068 *22 May 200621 Sep 2006Advanced Cardiovascular Systems, Inc.Embolic protection device with an elongated superelastic radiopaque core member
US20070005131 *13 Jun 20054 Ene 2007Taylor David MHeart valve delivery system
US20070088431 *18 Oct 200519 Abr 2007Henry BourangHeart valve delivery system with valve catheter
US20070249965 *10 Abr 200725 Oct 2007Advanced Cardiovascular System, Inc.Superelastic guiding member
US20080027532 *10 Oct 200731 Ene 2008Abbott Cardiovascular Systems Inc.Radiopaque nitinol alloys for medical devices
US20080065011 *10 Sep 200713 Mar 2008Philippe MarchandIntegrated heart valve delivery system
US20080161910 *14 Mar 20083 Jul 2008Revuelta Jose MReplacement prosthetic heart valve, system and method of implant
US20090248130 *11 Feb 20091 Oct 2009Abbott Cardiovascular Systems, Inc.Nitinol alloy design and composition for vascular stents
US20110054596 *12 Ago 20103 Mar 2011Edwards Lifesciences CorporationMethod of Delivering a Prosthetic Heart Valve
WO2006005015A3 *30 Jun 200527 Abr 2006Edwards Lifesciences Pvt IncParavalvular leak detection, sealing and prevention
WO2014182691A2 *6 May 201413 Nov 2014Fort Wayne Metals Research Products Corp.Titanium-niobium-hafnium alloy shape memory wire
WO2014182691A3 *6 May 201422 Ene 2015Fort Wayne Metals Research Products Corp.Titanium-niobium-hafnium alloy shape memory wire
Clasificaciones
Clasificación de EE.UU.600/407
Clasificación internacionalA61M25/09, C22C30/00, C22F1/00, A61L31/02, C22C14/00
Clasificación cooperativaC22C30/00, A61M2025/09083, C22F1/006, A61M25/09, A61M2205/0266, A61L31/14, A61M2025/09008, A61M2025/09175, A61L31/022, A61L2400/16, C22C14/00, A61M2025/09141
Clasificación europeaA61L31/14, C22F1/00M, A61L31/02B, C22C14/00, A61M25/09, C22C30/00